Nagaraja NV

No ORCID on file · 1 paper in corpus
rct 2000
Journal of clinical pharmacology ·doi:10.1177/00912700022008937

Cetrorelix (CET), a potent luteinizing hormone-releasing hormone (LH-RH) antagonist, was recently approved for the prevention of premature ovulation in patients undergoing a controlled ovarian stimulation (COS), followed by oocyte pickup an…